Published February 19, 2018
Insulin is a hormone; a chemical messenger produced in one part of the body to have an action on another. It is a protein responsible for regulating blood glucose levels as part of metabolism. The body manufactures insulin in the pancreas, and the hormone is secreted by its beta cells, primarily in response to glucose. The beta cells of the pancreas are perfectly designed “fuel sensors” stimulated by glucose.
North America Insulin Market Segments Size & Growth:
North America Insulin Market size is projected to reach approximately $ XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Growth in the Number of Diabetic Patients, Increasing Population Exposure to Key Risk Factors Leading to Diabetes, Rising Market Demand for HI Analogs, Technological Advancements in HI Delivery Devices, and Favourable Medical Reimbursement Scenario in Developed Countries. However, Stringent Regulatory Requirements for Product Approvalisthereby hampering the market growth.
North America Insulin Market Segments Share:
North America Insulin Market is categorised into product type which comprises drugs, and Delivery Devices. Among them, Drugs segment is expected to have largest market size during the forecast period because of its excess demand, rising proportion of the ageing population in developed countries, and Others. By Type, the market is segmented intoInsulin Analogs, Biosimilars, and Biologics. Among them, Biosimilars segment is expected to have largest market share during the forecast period because of its low-cost therapy. By Delivery Devices, the market is segmented into Syringes, Pens, and Pen Needles. Among them, Pens segment is expected to have largest market share during the forecast period because of the emerging markets. By Application, the market is segmented into Type I Diabetes, and Type II Diabetes. By Geography, USA holds the largest market share and is expected to maintain its dominant position during the forecast period. The changing lifestyle and lifestyle-related disorders are increasing the number of diabetic patients. High investments and involvement of more and more companies in research and development of insulin analogues and many ongoing clinical trials have created an environment for higher market growth shortly.
North America Insulin Market Trends:
North America Insulin Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
North America Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.
Expertise investment opportunities b an analyst to the individual and organisation to have a better foothold in the market.
The major market players, such as
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.4 SWOT Analysis
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1.1 Growth in the Number of Diabetic Patients
4.1.2 Increasing Population Exposure to Key Risk Factors Leading to Diabetes
4.1.3 Rising Market Demand for HI Analogs
4.1.4 Technological Advancements in HI Delivery Devices
4.1.5 Favourable Medical Reimbursement Scenario in Developed Countries
4.2.1 Stringent Regulatory Requirements for Product Approval
4.3.1 Expected Patent Expiry of Key HI Drugs
4.3.2 Emerging Markets
4.4.1 High Product Manufacturing Costs
Chapter 5 North America Insulin Market– By Product Type
5.2 Delivery Devices
Chapter 6 North America Insulin Market– By Type
6.1 Insulin Analogs
Chapter 7 North America Insulin Market- By Delivery Devices
7.3 Pen Needles
Chapter 8 North America Insulin Market- By Application
8.1 Type I Diabetes
8.2 Type II Diabetes
Chapter 9 North America Insulin Market- By Geography
Chapter 10 North America Insulin Market- Company Profiles
10.1B. Braun Melsungen AG
10.1.1. Company Overview
10.1.2. Business Segments
10.1.3. Financial Performance ( Public Enterprises)
10.1.4. SWOT Analysis
10.2 Biocon Limited
10.3 Becton, Dickinson and Company
10.4 Eli Lilly and Company
10.5 Biodel Inc.
10.7 NOVO Nordisk A/S
10.9 Wockhardt Limited
10.10 Ypsomed AG
10.11 Oramed Pharmaceuticals Inc.
10.12 Dongbao Enterprises Group Co. Ltd.
10.13 Merck & Co.
10.14 GlaxoSmithKline Plc
Chapter 10 North America Insulin Market- Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures